Literature DB >> 11338220

Pulmonary function tests in beta thalassemia.

M Arora1, J Chandra, J C Suri, S Narayan, A K Dutta.   

Abstract

To study pulmonary function tests (PFT) in multiple transfusion recipient thalassemics, PFTs were done for 30 thalassemics and 20 matched controls. Confirmed cases of thalassemia on regular transfusion therapy were the subject of study. Apart from history and physical examination of the thalassemics, serum ferritin estimation and spirometry were done. Parameters studied included lung volumes--functional residual capacity (FRC), forced vital capacity (FVC), residual volume (RV) and total lung capacity (TLC); and flow rates--forced expiratory volume in one second (FEV1), forced expiratory volume in 1 second/forced vital capacity (FEV1/FVC), peak expiratory flow 25-75 (PEF 25-75%) and peak expiratory flow rate (PEFR). Single breath carbon monoxide diffusing capacity (DLco) and arterial blood gas (ABG) were also analysed. The mean height and weight of thalassemics were below that of age matched controls. A restrictive abnormality in PFT was found in 86.6% cases. These patients were found to have a decrease in all the lung volumes namely FVC, FRC, RV and TLC with a proportional decrease in the flow rates, FEV1, PEF 25-75% and PEF with a normal (> 0.75) FEV1/FVC ratio. DLco was decreased in all the patients with restrictive lung disease and fall in DLco showed a good correlation (r = 0.7, P < .001) with the severity of restrictive disease suggesting that some intrapulmonary pathology is likely to be responsible for the restrictive pattern. None of the cases had an obstructive or mixed pattern of pulmonary dysfunction. No correlation was found between severity of restrictive disease and the serum ferritin levels. A negative correlation with degree of hepatosplenomegaly was found. No correlation was found between severity of the defect and age, number of blood transfusions received and hemoglobin at the time of doing the test. To conclude, restrictive lung disease is the predominant abnormality in multi-transfused thalassemics, which is probably due to pulmonary parenchymal pathology. The abnormality of PFTs is not directly related to iron overload.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11338220     DOI: 10.1007/BF02723198

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  12 in total

1.  Cardiopulmonary assessment in beta-thalassemia major.

Authors:  D Grisaru; E A Rachmilewitz; M Mosseri; M Gotsman; J S Lafair; E Okon; A Goldfarb; Y Hasin
Journal:  Chest       Date:  1990-11       Impact factor: 9.410

2.  Thalassemia: lung function with reference to iron studies and reactive oxidant status.

Authors:  D K Luyt; G A Richards; H Roode; R J Dowdeswell; A J van Rensburg; S G Reinach
Journal:  Pediatr Hematol Oncol       Date:  1993 Jan-Mar       Impact factor: 1.969

Review 3.  Management of thalassemias: growth and development, hormone substitution, vitamin supplementation, and vaccination.

Authors:  C A Kattamis; A C Kattamis
Journal:  Semin Hematol       Date:  1995-10       Impact factor: 3.851

4.  Office pulmonary function testing.

Authors:  M A Wall
Journal:  Pediatr Clin North Am       Date:  1984-08       Impact factor: 3.278

5.  Survival and causes of death in thalassaemia major.

Authors:  M G Zurlo; P De Stefano; C Borgna-Pignatti; A Di Palma; A Piga; C Melevendi; F Di Gregorio; M G Burattini; S Terzoli
Journal:  Lancet       Date:  1989-07-01       Impact factor: 79.321

6.  Pulmonary function in thalassemia major.

Authors:  K P Fung; O K Chow; S Y So; P M Yuen
Journal:  J Pediatr       Date:  1987-10       Impact factor: 4.406

7.  Pulmonary function abnormalities in homozygous beta-thalassemia.

Authors:  R W Hoyt; N Scarpa; R W Wilmott; A Cohen; E Schwartz
Journal:  J Pediatr       Date:  1986-09       Impact factor: 4.406

8.  Pulmonary function abnormalities in thalassemia patients on a hypertransfusion program.

Authors:  T G Keens; M H O'Neal; J A Ortega; C B Hyman; A C Platzker
Journal:  Pediatrics       Date:  1980-05       Impact factor: 7.124

Review 9.  Pulmonary function in infants and children.

Authors:  J K Pfaff; W J Morgan
Journal:  Pediatr Clin North Am       Date:  1994-04       Impact factor: 3.278

10.  Pulmonary function abnormalities in thalassemia major and the role of iron overload.

Authors:  J M Factor; S R Pottipati; I Rappoport; I K Rosner; M L Lesser; P J Giardina
Journal:  Am J Respir Crit Care Med       Date:  1994-06       Impact factor: 21.405

View more
  4 in total

1.  Pulmonary Functions in Transfusion-Dependent Thalassemia.

Authors:  Jagdish Chandra; Smriti Rohatgi
Journal:  Indian Pediatr       Date:  2022-06-15       Impact factor: 3.839

2.  Pulmonary Function Tests in Sickle Cell Disease.

Authors:  Raviraj Purohit; Sanjeev S Rao; Jagdish P Goyal; Vijay B Shah; Jaykaran Charan
Journal:  Indian J Pediatr       Date:  2016-03-05       Impact factor: 1.967

3.  An evaluation of thyroid autoimmunity in patients with beta thalassemia minor: A case-control study.

Authors:  Ali Ramazan Benli; Sati Sena Yildiz; Mehmet Ali Cikrikcioglu
Journal:  Pak J Med Sci       Date:  2017 Sep-Oct       Impact factor: 1.088

4.  Hyperventilation with Maintenance of Isocapnia. An "Old New" Method in Carbon Monoxide Intoxication.

Authors:  Jacek Sein Anand; Daria Schetz; Wojciech Waldman; Marek Wiśniewski
Journal:  PLoS One       Date:  2017-01-20       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.